Belgium· BE-AMP-SAM331895-00
Cisplatine Teva 0,5 mg/ml
A cisplatin product containing cisplatin, registered in Belgium by Teva Pharma Belgium. The same ATC class is registered in 16 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Cisplatin is registered in 16 of 19 countries.
Countries holding a registration under ATC L01XA01 (cisplatin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 8 of them publish a price we can compare per daily dose
Cisplatin · ATC L01XA01
16 / 19 countries
- Belgiumprice
- Canada
- Czechiaprice
- Denmark
- Finlandprice
- Franceprice
- Germany
- Ireland
- Japan
- Netherlands
- Norwayprice
- Polandprice
- Sweden
- Switzerlandprice
- United Kingdom
- United Statesprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Cisplatin
- Manufacturer
- Teva Pharma Belgium
- Country
- Belgium (BE)
- ATC code
- L01XA01
- ATC class
- Cisplatin
- Defined daily dose
- 6.75 mg, P
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
593 interactions on record for cisplatin.
Graded by severity as the source publishes them — 65 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Cisplatin · interactions on record
593 records
- 65 severe
- 252 moderate
- 20 minor
- 256 info
Most severe, free to view
- AmiodaroneC01BD01severe
- DofetilideC01BD04severe
- DronedaroneC01BD07severe
- EtelcalcetideH05BX04severe
- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Cisplatin in 15 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- FinlandCisplatin EbeweEbewe Pharma Ges.m.b.H. Nfg.KG
- United KingdomCisplatin 100mg/1000ml in Sodium chloride 0.9% infusion bagsSpecial Order
- United StatesCisplatinFresenius Kabi USA, LLC
- SwitzerlandCisplatin Accord
- GermanyCisplatin AccordAccord Healthcare B.V.
- Japanシスプラチン日本化薬
- FranceCISPLATINE ACCORD 1 mg/ml, solution à diluer pour perfusionACCORD HEALTHCARE FRANCE
- SpainCISPLATINO ACCORD 1 mg/ml CONCENTRADO PARA SOLUCION PARA PERFUSION EFGAccord Healthcare S.L.U.
Authorised across Europe · EMA
The same active substance is authorised in 27 EEA countries. Names it is sold under:
- Austria · Cisplatin Accord, Cisplatin Ebewe
- Bulgaria · Цисплатин Акорд, Цисплатин Ебеве
- Cyprus · Cisplatin Accord Healthcare, Cisplatin Pfizer Hellas
- Czechia · Cisplatin Ebewe
- Germany · Cisplatin Accord, Cisplatin Hikma
- Denmark · Cisplatin "ebewe", Cisplatin Accord
- Estonia · Cisplatin Accord
- Spain · Cisplatino Accord, Cisplatino Hikma
- Finland · Cisplatin Accord, Cisplatin Ebewe
- France · Cisplatine Accord, Cisplatine Hikma
- United Kingdom (Northern Ireland) · Cisplatin, Cisplatin Accord Healthcare
- Greece · Cisplatin Hospira, Oncoplat
- Croatia · Cisplatin Pliva, Cisplatin Pontus
- Hungary · Cisplatin Accord, Cisplatin Sandoz
- Ireland · Cisplatin Accord Healthcare Ireland, Cisplatin Pfizer Healthcare Ireland
- Italy · Cisplatin Teva, Cisplatino Accord Healthcare Italia
- Lithuania · Cisplatin Accord
- Luxembourg · Cisplatine Teva
- Latvia · Cisplatin Accord
- Malta · Cisplatin Accord Healthcare
- Netherlands · Cisplatine Accord, Cisplatine Hikma
- Norway · Cisplatin Accord
- Poland · Cisplatin Ebewe, Cisplatinum Accord
- Portugal · Cisplatina Accord, Cisplatina Hikma
- Romania · Cisplatină Accord
- Sweden · Cisplatin Accord, Cisplatin Ebewe
- Slovenia · Cisplatin Accord
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/d42cde69-6472-4c39-80f4-45f7add08ad6 GET /v1/drugs/d42cde69-6472-4c39-80f4-45f7add08ad6?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Concentrate for solution for infusion",
"source": "afmps",
"status": "REVOKED",
"name_en": "Cisplatine Teva 0,5 mg/ml",
"name_fr": "Cisplatine Teva 0,5 mg/ml",
"name_nl": "Cisplatine Teva 0,5 mg/ml",
"amp_code": "SAM331895-00",
"strengths": [
"0.5000"
],
"pack_count": 1,
"substances": [
"Cisplatin"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Cisplatin",
"authorisation_numbers": [
"BE331895"
]
}See everything about cisplatin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.